Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C5H11NO2 |
| Molecular Weight | 117.1463 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC[C@H](N)C(O)=O
InChI
InChIKey=SNDPXSYFESPGGJ-BYPYZUCNSA-N
InChI=1S/C5H11NO2/c1-2-3-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1
| Molecular Formula | C5H11NO2 |
| Molecular Weight | 117.1463 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1914279 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21955456 |
46.0 mM [Ki] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| RNAi-mediated suppression of isoprene emission in poplar transiently impacts phenolic metabolism under high temperature and high light intensities: a transcriptomic and metabolomic analysis. | 2010-09 |
|
| Caloric restriction reverses high-fat diet-induced endothelial dysfunction and vascular superoxide production in C57Bl/6 mice. | 2010-05 |
|
| Specificities of olfactory receptor neuron responses to amino acids in the black bullhead catfish (Ameiurus melas). | 2010-02 |
|
| Glutathione-supported arsenate reduction coupled to arsenolysis catalyzed by ornithine carbamoyl transferase. | 2009-09-01 |
|
| Inhibition of S6K1 accounts partially for the anti-inflammatory effects of the arginase inhibitor L-norvaline. | 2009-03-13 |
|
| Kinetic and thermodynamic control in the stereoselective formation of trans- and cis-2-ferrocenyl-3-pivaloyl-4-alkyl-1,3-oxazolidin-5-ones. | 2009-02-07 |
|
| A 3(10)-helical pentapeptide in water: interplay of alpha,alpha-disubstituted amino acids and the central residue on structure formation. | 2009 |
|
| Molecular evolution of B6 enzymes: binding of pyridoxal-5'-phosphate and Lys41Arg substitution turn ribonuclease A into a model B6 protoenzyme. | 2008-06-19 |
|
| The crystal structures of ornithine carbamoyltransferase from Mycobacterium tuberculosis and its ternary complex with carbamoyl phosphate and L-norvaline reveal the enzyme's catalytic mechanism. | 2008-01-25 |
|
| Enzymatic evidence for the key role of arginine in nitrogen translocation by arbuscular mycorrhizal fungi. | 2007-06 |
|
| Structural and evolutionary bioinformatics of the SPOUT superfamily of methyltransferases. | 2007-03-05 |
|
| Intricate knots in proteins: Function and evolution. | 2006-09-15 |
|
| Arginase activity in a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans. | 2006-06 |
|
| Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. | 2004-12-14 |
|
| Arginase pathway in human endothelial cells in pathophysiological conditions. | 2004-08 |
|
| High glucose augments arginase activity and nitric oxide production in the renal cortex. | 2004-07 |
|
| Consumption of L-arginine mediated by Entamoeba histolytica L-arginase (EhArg) inhibits amoebicidal activity and nitric oxide production by activated macrophages. | 2004-04-01 |
|
| Kinetic analysis of phenylalanine dehydrogenase mutants designed for aliphatic amino acid dehydrogenase activity with guidance from homology-based modelling. | 2003-12 |
|
| Two new cyclosporin folds observed in the structures of the immunosuppressant cyclosporin G and the formyl peptide receptor antagonist cyclosporin H at ultra-high resolution. | 2003-05-07 |
|
| Changes in the ornithine cycle following ionising radiation cause a cytotoxic conditioning of the culture medium of H35 hepatoma cells. | 2003-02-10 |
|
| Arginine deprivation and tumour cell death: arginase and its inhibition. | 2003-02 |
|
| Resistance and susceptibility to Marek's disease: nitric oxide synthase/arginase activity balance. | 2002-05-01 |
|
| Sulfamide antifolates inhibiting thymidylate synthase: synthesis, enzyme inhibition and cytotoxicity. | 2002 |
|
| Conversion of a glutamate dehydrogenase into methionine/norleucine dehydrogenase by site-directed mutagenesis. | 2001-11 |
|
| Human ornithine transcarbamylase: crystallographic insights into substrate recognition and conformational changes. | 2001-03-15 |
|
| Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. | 2001-02-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:30:24 GMT 2025
by
admin
on
Mon Mar 31 18:30:24 GMT 2025
|
| Record UNII |
A70UKS48FE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DSLD |
1076 (Number of products:82)
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
||
|
DSLD |
3256 (Number of products:105)
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
19475
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
229-543-3
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
SUB34283
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
C005313
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
NORVALINE
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
203786
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
6600-40-4
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
DTXSID701018015
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
18314
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
m8075
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
65098
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
DB04185
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
100000127966
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY | |||
|
A70UKS48FE
Created by
admin on Mon Mar 31 18:30:24 GMT 2025 , Edited by admin on Mon Mar 31 18:30:24 GMT 2025
|
PRIMARY |